Blink Device Company Announces TwitchView™ Quantitative Monitor for Neuromuscular Blockade is Now Compatible with Philips IntelliVue Patient Monitors

SEATTLE, WA MARCH 13, 2018 - Blink Device Company announced today that the TwitchView™, a new quantitative train-of-four monitor for neuromuscular blockade, integrates with Philips IntelliVue Patient Monitors. Commercially available in the United States, Europe, and South Korea, the TwitchView™ neuromuscular TOF monitor uses gold-standard electromyography (EMG) to provide clinicians with reliable and accurate real-time data to support drug dosing decisions and reversal timing. The TwitchView is now is compatible with Philips IntelliVue Patient Monitors through the Philips IntelliBridge EC10/EC5 (#104) module, displaying real-time neuromuscular blockade status on the vital sign monitor and facilitating automated data logging into the electronic medical record.

Karl Schmidt, Blink’s COO and co-founder, said, “Quantitative neuromuscular monitoring is rapidly becoming the standard of care when neuromuscular blocking agents are administered, and hospitals want streamlined technologies that integrate into their electronic medical records. Partnering with industry leaders such as Philips provides flexibility for data viewing and a seamless pathway for data to enter the EMR. Our mission is to provide technology that improves patient safety and meets the needs of physicians and hospitals. Making our data easily accessible and readily available to clinicians and researchers is a top priority.”